Artificial Intelligence Enhanced Remote Monitoring in Interstitial Lung Disease
This study explores a new way to monitor people with a serious lung condition called fibrotic interstitial lung disease (fILD). It uses an AI system that helps doctors keep an eye on patients remotely. The AI looks at information gathered at home, like lung function and symptoms, to notice patterns that might mean someone's condition is changing. The main goal is to find out if this AI monitoring is practical, safe, and acceptable for patients and their healthcare teams. It's important to know if it can reliably help identify when someone's lung condition might be getting worse, allowing doctors to act sooner. The AI supports doctors, it doesn't make decisions itself.
At a glance
What is this study about?
This research study is about finding new ways to help people living with a serious lung condition called fibrotic interstitial lung disease (fILD). This condition causes scarring in the lungs, making it harder to breathe over time. In this study, we're looking at a special type of remote monitoring that uses artificial intelligence (AI).
Remote monitoring means keeping an eye on your health from home, without needing to visit the hospital as often. The AI system acts like a smart helper, looking at information you provide – such as your lung function and how you're feeling – to spot any subtle changes that might suggest your condition is getting worse. The aim is to see if this early warning system can help your healthcare team respond more quickly if needed.
It's important to understand that the AI doesn't replace your doctor or make any decisions about your treatment. Instead, it works with your healthcare team, giving them extra information to consider. They will always review any alerts from the AI before deciding if any action is needed. This study is testing if this AI-enhanced remote monitoring is practical, safe, and helpful for both patients and the healthcare staff who look after them.
Key takeaways
- This study uses AI to help monitor a lung condition called fILD from home.
- The AI helps doctors spot if your lung condition might be getting worse, but it doesn't make treatment decisions.
- Participation involves weekly home monitoring of lung function and symptoms, plus questionnaires.
- You will continue to receive your usual medical care during the study.
- The study lasts about 12 months, and you can withdraw at any time.
- This is a research study to see if the AI system is practical and helpful.
Who may be eligible?
To join this study, you need to be an adult aged 18 or over and have a confirmed diagnosis of fibrotic interstitial lung disease (fILD). Your lung function, specifically a measure called 'Forced Vital Capacity', needs to be above a certain level (more than 45%). You also need to be able to use a home spirometer, which is a device that measures your breathing, safely and reliably.
You'll need access to a smartphone or tablet that can connect to the internet, as you'll be using an app for monitoring. It's also important that you can understand what the study involves, talk to the research team, and fill in questionnaires.
There are some reasons why you might not be able to join. For example, if you've recently had a flare-up of your lung condition, have another serious illness that might affect your participation, or if your doctors think your life expectancy is less than 6 months. Also, if you've taken part in a previous study called REMILD, you won't be able to join this one.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years old or older?
- Do you have a diagnosis of fibrotic interstitial lung disease (fILD)?
- Can you use a home device to measure your breathing safely?
- Do you have a smartphone or tablet with internet access?
- Are you able to understand the study and complete questionnaires?
What does participation involve?
If you decide to take part in this study, you'll be involved for about 12 months. During this time, you will continue to receive your usual medical care from your doctors.
Each week, you'll be asked to measure your lung function and oxygen levels at home using special devices that connect to an app. You'll also use the patientMpower app to report how breathless you feel and if you have a cough. Every three months, you'll fill out questionnaires about your health and how you find using the remote monitoring system.
Some people in the study, and also some healthcare professionals, might be invited to interviews or group discussions to share their experiences of using the AI-enhanced remote monitoring. There are no special visits required beyond your usual care, but you'll be actively monitoring your health from home.
Potential risks and benefits
Locations (1)
- King's College LondonVerified postcodeLondon, United Kingdom
Common questions
What is AI-enhanced remote monitoring?
It's a system that uses artificial intelligence to look at your health information, collected from home, to help your doctor spot any changes in your lung condition.
Will the AI make decisions about my treatment?
No, absolutely not. The AI is a tool to support your healthcare team. Your doctors will always review any information from the AI and make all treatment decisions.
How long will I be in the study?
You will take part in the study for about 12 months.
Do I have to go to extra hospital appointments?
No, you will continue with your usual hospital appointments and care. The study mainly involves monitoring your health from home.
What happens if I change my mind about participating?
You can withdraw from the study at any time, for any reason, and it will not affect the medical care you receive.
How to find out more
Marium Naqvi, MPharm MScPP
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.